Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Saline control

Preclinical

DD. Bradley Welling, MD, PhD

1

Indications

2

Total Trials

2

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Tympanic Membrane PerforationActive, not recruiting

Tympanic Membrane PerforationPreclinical

Active, not recruiting

Timeline

Expected Milestones

Q4 2026

PreclinicalActive, not recruiting

Tympanic Membrane Perforation

NCT06448039

Q4 2027

Phase 1Recruiting

Venous Distension Reflex

NCT03513770

Clinical

Trials by Indication[1]

Venous Distension Reflex1 trial

Autonomic Control of the Circulation and the Venous Distension Reflex

Recruiting·MMilton S. Hershey Medical Center·Phase 1·NCT03513770·18 enrolled

Tympanic Membrane Perforation1 trial

In-office Repair of Chronic Tympanic Membrane Perforations

Active, not recruiting·DD. Bradley Welling, MD, PhD·Preclinical·NCT06448039·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Saline control. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Saline control. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — D. Bradley Welling, MD, PhD company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: DD. Bradley Welling, MD, PhD

Related News